Brief: Revelation Biosciences Inc Announces Initiation Of A Phase 2B Study To Assess Efficacy Of Intranasal Revtx-99

Revelation Biosciences

01/12/2021 21:35

Dec 1 (Reuters) - Petra Acquisition Inc  PAIC.O :
    * REVELATION BIOSCIENCES INC. ANNOUNCES INITIATION OF A
PHASE 2B
STUDY TO ASSESS EFFICACY OF INTRANASAL REVTX-99 FOR THE
PREVENTION OF H3N2 INFLUENZA

Source text for Eikon:  ID:nGNX5JT868 
Further company coverage:  PAIC.O